Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Graeff

Showing results (201-210 of 206) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 206 results.
The International Journal of Biological Markers|April 14, 2000
Tumor-biological factors uPA and PAI-1 as stratification criteria of a multicenter adjuvant chemotherapy trial in node-negative breast cancerA Prechtl, N Harbeck, C Thomssen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucoseN Avril, J Dose, F Jänicke, et al.
International Journal of Oncology|June 19, 1998
Disease-adapted relapse therapy for ovarian cancer: results of a prospective studyW Kuhn, B Schmalfeldt, L Pache, et al.
British Journal of Cancer|April 17, 1999
Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIcW Kuhn, B Schmalfeldt, U Reuning, et al.
Biological Chemistry|March 1, 1997
Inhibition of the interaction of urokinase-type plasminogen activator (uPA) with its receptor (uPAR) by synthetic peptidesM Bürgle, M Koppitz, C Riemer, et al.
The Journal of Clinical Investigation|April 29, 1998
Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activityY Zhang, H Weiler-Guettler, J Chen, et al.
Pageof 21

Showing results (201-210 of 206) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 206 results.
The International Journal of Biological Markers|April 14, 2000
Tumor-biological factors uPA and PAI-1 as stratification criteria of a multicenter adjuvant chemotherapy trial in node-negative breast cancerA Prechtl, N Harbeck, C Thomssen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucoseN Avril, J Dose, F Jänicke, et al.
International Journal of Oncology|June 19, 1998
Disease-adapted relapse therapy for ovarian cancer: results of a prospective studyW Kuhn, B Schmalfeldt, L Pache, et al.
British Journal of Cancer|April 17, 1999
Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIcW Kuhn, B Schmalfeldt, U Reuning, et al.
Biological Chemistry|March 1, 1997
Inhibition of the interaction of urokinase-type plasminogen activator (uPA) with its receptor (uPAR) by synthetic peptidesM Bürgle, M Koppitz, C Riemer, et al.
The Journal of Clinical Investigation|April 29, 1998
Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activityY Zhang, H Weiler-Guettler, J Chen, et al.
Pageof 21